Structural MRI measures in Alzheimer’s disease and effects of ethnicity
Background:
Worldwide, Alzheimer's disease (AD) is the most common form of dementia, posing a major burden for healthcare (~US$604 billion spent in 2010). In Hong Kong, 6.1% of people aged 70+ have dementia, 65% of which is AD. It is estimated that many others are misdiagnosed, so actual incidence rate may be even higher.
At present, there is no cure but early diagnosis and intervention can slow disease progression. The current gold standard for diagnosing AD is through cognitive tests, but this can only catch symptomatic patients. Presently, definitive diagnosis can only be made post-mortem. Neuroimaging is non-invasive, safe, and can measure many variables visually and quantitatively. Structural MRI measures such as hippocampal volumetry and cortical thickness have been shown to decrease with disease progression. Manual hippocampal volumetry is currently the gold standard for obtaining these measures, but semi-automatic data analysis programs, such as FreeSurfer (http://surfer.nmr.mgh.harvard.edu/), have been shown to provide similar levels of accuracy.
There is speculation that ethnicity may be a confounding variable when conducting large population studies. Morphometric differences between European and Japanese brains have been found, though the implications for subcortical structures are unknown. Genetically, the APOE allele frequency is known to be slightly different between ethnic groups, and it has been postulated that APOE genotypes can affect cortical thickness. With the increasing number of collaborative international neuroimaging studies, the effect of ethnicity on these measures should be investigated.
Purpose:
In our study, we will run the same structural MRI analyses using FreeSurfer on a local Chinese cohort and a matched Caucasian cohort obtained from the Alzheimer's Disease Neuroimaging Initiative’s database to address the following questions:
1. Will the use of cortical thickness and hippocampal volume combined increase sensitivity and specificity for AD than individually?
2a. Is it possible that ethnicity can have an effect on cortical thickness and brain morphometry?
2b. If so, would future cohorts need to be analysed separately using population-specific templates?